REFRAME
DEAD

Serial Number

98023354

Owner

SUTRO BIOPHARMA, INC.

Attorney

Karen Won

Filing Date

Jun 1, 2023

Add to watchlist:

No watchlists yet
View on USPTO

REFRAME Trademark

Serial Number: 98023354

REFRAME is a trademark filed by SUTRO BIOPHARMA, INC. on June 1, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

SUTRO BIOPHARMA, INC. (24 trademarks)

310 Utah Avenue, Suite 150
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

June 1, 2023

Registration Date

Not Registered

Published for Opposition

May 21, 2024

Goods & Services

Medical scientific research, medical scientific development, and medical scientific testing of antibody-drug conjugates and cancer therapies; Providing medical scientific research information in the field of antibody-drug conjugates and cancer therapies; Scientific investigations for medical purposes featuring clinical trials

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 18, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 18, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 16, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 15, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 15, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 5, 2023 NWOS
NEW APPLICATION ENTERED
Jun 5, 2023 NWAP